Jupiter Life Line Hospitals logo

Jupiter Life Line Hospitals CEO, MD, chairman, board of directors and AGM

NSE: JLHLBSE: 543980Healthcare ServicesSmall Cap

Last close ₹244.00up ₹0.95 (0.39%)BSE ₹244.25

Share price at the NSE close on 23 Oct 2026. Previous close ₹243.05.

52-week range of traded prices to 23 Oct 2026
₹233.40Low, 23 Oct 2026₹340.00High, 30 Jul 2026
Market cap
₹7,999 Cr604th largest listed
P/E
Earlier quarters restated in the year
P/B
5.2
Dividend yield
0.08%
ROCE
12.2%
Debt to equity
0.33
Volume, NSE
2,98,24550.6% delivered

Jupiter Life Line Hospitals board of directors

At the end of the quarter to Sep 2026, as the company filed it; changes since are in its announcements.Their trades in its shares

  • ChairpersonAJAY PRATAP THAKKERRelated to the promoter
  • Managing director and CEOANKIT AJAY THAKKER
  • Company Secretary and Compliance OfficerSuma Upparatti

8 directors5 independent2 executive1 non-executive

  • AJAY PRATAP THAKKER · ChairpersonExecutive · joined Nov 2002 · 1 listed board
  • ANKIT AJAY THAKKER · Managing director and CEOExecutive · joined Jun 2016 · 1 listed board · 1 committee seat
  • VADAPATRA SAYEE RAGHAVANNon-executive · joined Sep 2009 · 1 listed board · 3 committee seats, 1 as chair
  • DARSHAN HIRALAL VORAIndependent · joined Sep 2018 · reappointed Sep 2023 · 96 months as independent · 1 listed board · 1 as independent · 1 committee seat
  • JASMIN A PATELIndependent · joined Sep 2018 · reappointed Sep 2023 · 96 months as independent · 1 listed board · 1 as independent
  • URMI ASHVIN POPATIndependent · joined Feb 2023 · reappointed Feb 2023 · 43 months as independent · 1 listed board · 1 as independent · 3 committee seats
  • SATISH UTEKARIndependent · joined Feb 2023 · reappointed Feb 2023 · 43 months as independent · 1 listed board · 1 as independent · 1 committee seat, 1 as chair
  • AMAR HARISHCHANDRA MANJREKARIndependent · joined Aug 2024 · reappointed Aug 2024 · 25 months as independent · 1 listed board · 1 as independent

An independent director has no business or family tie to the company, its promoters or its managers beyond the seat. Listed boards counts the boards of listed companies the director sits on, this one included, and "as independent" how many of those seats are independent ones. Committee seats are audit and stakeholder committee seats across those companies. Months as independent is filed for independent directors only, whose terms the rules cap. Disqualified is the company's own mark that a director may not serve under company law.

1 director who left
  • BHASKAR PRATAPRAI SHAH, left 14 May 2026: Others

Committees and meetings

Who sits on each, and how often they met.Board meeting notices and outcomes

  • Board

    • 31 Jul 20268 of 8 present5 independent · 76 days in between
    • 15 May 20268 of 8 present5 independent

  • Audit Committee

    Chair SATISH UTEKAR

    DARSHAN HIRALAL VORA, VADAPATRA SAYEE RAGHAVAN, URMI ASHVIN POPAT

    • 31 Jul 20264 of 4 present3 independent · 76 days in between
    • 15 May 20264 of 4 present3 independent

  • Nomination and remuneration committee

    Chair DARSHAN HIRALAL VORA

    SATISH UTEKAR, VADAPATRA SAYEE RAGHAVAN, URMI ASHVIN POPAT

    • 31 Jul 20264 of 4 present3 independent · 76 days in between
    • 15 May 20264 of 4 present3 independent

  • Stakeholders Relationship Committee

    Chair VADAPATRA SAYEE RAGHAVAN

    ANKIT AJAY THAKKER, URMI ASHVIN POPAT

    • 15 May 20263 of 3 present1 independent

  • Risk Management Committee

    Chair VADAPATRA SAYEE RAGHAVAN

    SATISH UTEKAR, AMAR HARISHCHANDRA MANJREKAR

    • 15 May 20263 of 3 present2 independent

  • Corporate Social Responsibility Committee

    Chair URMI ASHVIN POPAT

    JASMIN A PATEL, DARSHAN HIRALAL VORA

    • 15 May 20262 of 2 present2 independent

Meetings in the quarter filed and the one before it. The days in between are as the company files them, neither meeting's day counted; the rules allow at most 120. A quorum is the least number of members who must attend for the meeting to decide anything.

Statutory auditors

Named in the results for the quarter to Mar 2026.

  • Aswin P. Malde & Co, Chartered AccountantsPeer-review certificate valid to Feb 2029
  • KKC & Associates LLP Chartered AccountantsPeer-review certificate valid to Jul 2027
1 earlier auditor
  • M/s Aswin P Malde & Co.Named in the filing for the quarter to Mar 2025

A statutory auditor checks the company's accounts and signs its results. Peer review is the accountants' institute's check of an audit firm's own work, which a listed company's auditor must hold a valid certificate of.

Jupiter Life Line Hospitals AGM and shareholder votes

Each resolution, how the votes went, and how institutions voted apart from the promoters. A postal ballot is a vote by post or online, held without a meeting.Jupiter Life Line Hospitals dividend history

Annual general meeting, 17 Jul 2026

32,977 shareholders on the register on 10 Jul 2026; present: 8 promoters and 40 others; votes counted by Vaibhav Dandawate / Makarand M. Joshi & Co..The company's voting result (opens in a new tab)

  1. Adoption of the Audited Standalone Financial Statements for the financial year ended March 31, 2026.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 85.95% · promoters 100.00% · institutions 87.61% · other public 66.94%

  2. Adoption of the Audited Consolidated Financial Statements for the financial year ended March 31, 2026.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 85.95% · promoters 100.00% · institutions 87.61% · other public 66.94%

  3. Appointment of Dr. Ajay Thakker (DIN: 00120887) who retires by rotation.
    OrdinaryPromoters have an interest in it
    99.95% for0.05% against

    Against: promoters 0.00% · institutions 0.19% · other public 0.00%

    Turnout: all 85.95% · promoters 100.00% · institutions 87.61% · other public 66.94%

  4. Appointment with change in designation and remuneration of Dr. Ajay Thakker (DIN: 00120887) as Chairman & Whole Time Director with effect from 17th July, 2026.
    SpecialPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 85.95% · promoters 100.00% · institutions 87.61% · other public 66.94%

  5. Approve sub-division/split of equity shares of the Company.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 85.95% · promoters 100.00% · institutions 87.61% · other public 66.94%

  6. Approve the alteration of Capital Clause of Memorandum of Association of the Company.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 85.95% · promoters 100.00% · institutions 87.61% · other public 66.94%

  7. Approve the alteration of Articles of Association of the Company.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 85.95% · promoters 100.00% · institutions 87.61% · other public 66.94%

  8. Approval of Material Related Party Transaction with Jupiter Hospital Projects Private Limited.
    OrdinaryPromoters have an interest in it
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 42.82% · promoters 0.00% · institutions 87.61% · other public 60.15%

  9. Ratification of remuneration payable to M/s. V. J. Talati & Co., Cost Accountants, as Cost Auditors for the Financial Year 2026–27.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 85.95% · promoters 100.00% · institutions 87.61% · other public 66.94%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 11 Jul 2025, 10 resolutions

34,357 shareholders on the register on 4 Jul 2025; present: 7 promoters and 32 others; votes counted by Saurabh Agarwal / MMJB & Associates LLP Company Secretaries.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt: the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2025, including the reports of the Board of Directors and the Auditors thereon.MoreLess
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 84.14% · promoters 100.00% · institutions 91.08% · other public 59.45%

  2. To receive, consider and adopt: the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2025, including Auditors report thereon
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 84.14% · promoters 100.00% · institutions 91.08% · other public 59.45%

  3. To declare a final dividend of ₹ 1/- per Equity shares for the financial year ended March 31, 2025.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 84.14% · promoters 100.00% · institutions 91.08% · other public 59.45%

  4. To appoint a Director in place of Dr. Ankit Thakker (DIN: 02874715), who retires by rotation and being eligible offers himself for reappointmen
    OrdinaryPromoters have an interest in it
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.06% · other public 0.00%

    Turnout: all 84.14% · promoters 100.00% · institutions 91.08% · other public 59.45%

  5. To appoint, M/s. KKC & Associates LLP, Chartered Accountants as a (Sole/ Joint) Statutory Auditor for a period of five years.
    Ordinary
    99.98% for0.02% against

    Against: promoters 0.00% · institutions 0.07% · other public 0.00%

    Turnout: all 84.14% · promoters 100.00% · institutions 91.08% · other public 59.45%

  6. Appointment of Dr. Ankit Thakker (DIN: 02874715) as Joint Managing Director for a period of five years with effect from July 11, 2025.
    OrdinaryPromoters have an interest in it
    98.29% for1.71% against

    Against: promoters 0.00% · institutions 6.16% · other public 0.00%

    Turnout: all 84.14% · promoters 100.00% · institutions 91.08% · other public 59.45%

  7. Alteration of Memorandum of Association by Insertion of New Clause.
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 84.14% · promoters 100.00% · institutions 91.08% · other public 59.45%

  8. To Approve Material Related Party Transaction with Jupiter Hospital Projects Private Limited.
    Ordinary
    99.93% for0.07% against

    Against: promoters 0.00% · institutions 0.13% · other public 0.00%

    Turnout: all 41.02% · promoters 0.00% · institutions 91.08% · other public 52.85%

  9. Appointment of M/s. Yogesh Sharma & Co., as Secretarial Auditor of the Company for a period of five years.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 84.14% · promoters 100.00% · institutions 91.08% · other public 59.45%

  10. Ratification of remuneration payable to M/s. V. J. Talati & Co., Cost Accountants, as Cost Auditors for the Financial Year 2025 – 26.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 84.14% · promoters 100.00% · institutions 91.08% · other public 59.45%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Postal ballot, 27 Oct 2024, 1 resolution

The company's voting result (opens in a new tab)

  1. Appointment of Mr. Amar Manjrekar (DIN: 00463989) as a non-executive, Independent Director of the Company.n
    Special
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 69.03% · promoters 99.93% · institutions 77.16% · other public 24.38%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

Annual general meeting, 9 Aug 2024, 7 resolutions

Present: 8 promoters and 30 others.The company's voting result (opens in a new tab)

  1. To receive, consider and adopt:n(a) the Audited Standalone financial statements of the Company for the financial year ended March 31, 2024, including the reports of the Board of Directors and the Auditors thereon andn(b) the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2024, including with Auditors report thereon.MoreLess
    Ordinary
    99.92% for0.08% against

    Against: promoters 0.00% · institutions 0.34% · other public 0.00%

    Turnout: all 94.61% · promoters 99.93% · institutions 92.58% · other public 89.79%

  2. To declare a final dividend of ¿ 1/- per Equity shares for the financial year ended March 31, 2024.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 94.61% · promoters 99.93% · institutions 92.58% · other public 89.79%

  3. To appoint a Director in place of Dr. Bhaskar Shah (DIN: - 00007817), who retires by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    99.08% for0.92% against

    Against: promoters 0.00% · institutions 3.17% · other public 0.52%

    Turnout: all 94.61% · promoters 99.93% · institutions 92.58% · other public 89.79%

  4. To appoint a Director in place of Mr. Vadapatra Raghavan (DIN: - 00008182), who retires by rotation and being eligible, offers himself for re-appointment.
    Ordinary
    98.90% for1.10% against

    Against: promoters 0.00% · institutions 3.89% · other public 0.53%

    Turnout: all 94.00% · promoters 99.93% · institutions 92.58% · other public 88.04%

  5. Re-appointment and remuneration to Dr. Ajay Thakker (DIN: 00120887) as Managing Director for further period of 5 years from October 01, 2024.
    SpecialPromoters have an interest in it
    94.15% for5.85% against

    Against: promoters 0.00% · institutions 24.79% · other public 0.00%

    Turnout: all 94.61% · promoters 99.93% · institutions 92.58% · other public 89.79%

  6. Re-appointment and remuneration to Dr. Ankit Thakker (DIN: 02874715) as Whole Time Director for further period of 5 years from October 01, 2024.
    SpecialPromoters have an interest in it
    94.37% for5.63% against

    Against: promoters 0.00% · institutions 23.87% · other public 0.00%

    Turnout: all 94.61% · promoters 99.93% · institutions 92.58% · other public 89.79%

  7. Ratification of remuneration payable to M/s. V. J. Talati & Co., Cost Accountants, as Cost Auditors for the Financial Year 2024 - 2025.
    Ordinary
    100.00% for0.00% against

    Against: promoters 0.00% · institutions 0.00% · other public 0.00%

    Turnout: all 94.61% · promoters 99.93% · institutions 92.58% · other public 89.79%

For and against are per cent of the votes cast. Turnout is the votes cast as a per cent of the shares each group holds. Institutions are funds, insurers, banks and foreign investors. An ordinary resolution passes with more than half the votes cast, a special one with at least three quarters.

How mutual funds voted

Fund houses must disclose how they vote at every meeting of a company they hold.Funds that hold it

Mutual fund votes, meeting of 17 Jul 2026, 6 fund houses so far (houses' deadline to file 15 Oct 2026)

  • Adoption of the Audited Standalone Financial Statements for the financial year ended March 31, 2026.
    6 for0 against
  • Adoption of the Audited Consolidated Financial Statements for the financial year ended March 31, 2026.
    6 for0 against
  • Appointment of Dr. Ajay Thakker (DIN: 00120887) who retires by rotation.
    6 for0 against
  • Appointment with change in designation and remuneration of Dr. Ajay Thakker (DIN: 00120887) as Chairman & Whole Time Director with effect from 17th July, 2026.
    6 for0 against
  • Approve sub-division/split of equity shares of the Company.
    6 for0 against
  • Approve the alteration of Capital Clause of Memorandum of Association of the Company.
    6 for0 against
  • Approve the alteration of Articles of Association of the Company.
    6 for0 against
  • Approval of Material Related Party Transaction with Jupiter Hospital Projects Private Limited.
    6 for0 against
  • Ratification of remuneration payable to M/s. V. J. Talati & Co., Cost Accountants, as Cost Auditors for the Financial Year 2026–27.
    6 for0 against

Mutual fund votes, meeting of 11 Jul 2025, 13 fund houses

  • To receive, consider and adopt: the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2025, including the reports of the Board of Directors and the Auditors thereon.MoreLess
    13 for0 against
  • To receive, consider and adopt: the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2025, including Auditors report thereon
    13 for0 against
  • To declare a final dividend of ₹ 1/- per Equity shares for the financial year ended March 31, 2025.
    13 for0 against
  • To appoint a Director in place of Dr. Ankit Thakker (DIN: 02874715), who retires by rotation and being eligible offers himself for reappointmen
    13 for0 against
  • To appoint, M/s. KKC & Associates LLP, Chartered Accountants as a (Sole/ Joint) Statutory Auditor for a period of five years.
    Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance & Transparency concern: No justification provided for the difference in the proposed Auditor’s remuneration & existing auditor’s remuneration.
    11 for2 against
  • Appointment of Dr. Ankit Thakker (DIN: 02874715) as Joint Managing Director for a period of five years with effect from July 11, 2025.
    Against Bandhan Mutual Fund, HDFC Mutual Fund, Kotak Mahindra Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance Concern: No absolute cap on the remuneration.
    • HDFC Mutual FundDr. Ankit Thakker, 37, is part of the promoter family and currently serves as Wholetime Director and CEO at Jupiter Life Line Hospitals Limited. His proposed remuneration is not commensurate with the size of the business. We do not support the resolution.
    • Kotak Mahindra Mutual FundDr. Ankit Thakker, 37, is part of the promoter family and currently serves as Wholetime Director and CEO at Jupiter Life Line Hospitals Limited. His FY25 pay aggregated Rs. 25.9 mn. The company proposes to redesignate and appoint him as Joint Managing Director for a five-year term starting July 2025, at the remuneration terms approved at the 2024 AGM. While we support his appointment as Joint MD, we are unable to support the resolution given the open-ended nature of his remuneration terms. The limit of the remuneration proposed which is INR 60 mn is very high as compared to the previous year. Further, he and his family will also be eligible for medical reimbursements we believe the directors must bear their own personal expenses, and for any medical coverage, the company may consider acquiring health insurance. Hence, we are voting against.
    9 for4 against
  • Alteration of Memorandum of Association by Insertion of New Clause.
    13 for0 against
  • To Approve Material Related Party Transaction with Jupiter Hospital Projects Private Limited.
    Against Bandhan Mutual Fund, Motilal Oswal Mutual Fund, PGIM India Mutual Fund
    • Bandhan Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance & Transparency concern: Basis for Arm’s Length pricing is not disclosed; No justification as to how the purchase or sale of equipment falls within the ordinary course of business.
    • PGIM India Mutual FundCompliant with law. Governance & Transparency concern: Basis for Arm s Length pricing is not disclosed; No justification as to how the purchase or sale of equipment falls within the ordinary course of business.
    10 for3 against
  • Appointment of M/s. Yogesh Sharma & Co., as Secretarial Auditor of the Company for a period of five years.
    13 for0 against
  • Ratification of remuneration payable to M/s. V. J. Talati & Co., Cost Accountants, as Cost Auditors for the Financial Year 2025 – 26.
    13 for0 against
2 earlier meetings

Mutual fund votes, meeting of 27 Oct 2024, 13 fund houses

  • Appointment of Mr. Amar Manjrekar (DIN: 00463989) as a non-executive, Independent Director of the Company.n
    13 for0 against

Mutual fund votes, meeting of 9 Aug 2024, 13 fund houses

  • To receive, consider and adopt:n(a) the Audited Standalone financial statements of the Company for the financial year ended March 31, 2024, including the reports of the Board of Directors and the Auditors thereon andn(b) the Audited Consolidated Financial Statements of the Company for the financial year ended March 31, 2024, including with Auditors report thereon.MoreLess
    13 for0 against
  • To declare a final dividend of ¿ 1/- per Equity shares for the financial year ended March 31, 2024.
    13 for0 against
  • To appoint a Director in place of Dr. Bhaskar Shah (DIN: - 00007817), who retires by rotation and being eligible, offers himself for re-appointment.
    13 for0 against
  • To appoint a Director in place of Mr. Vadapatra Raghavan (DIN: - 00008182), who retires by rotation and being eligible, offers himself for re-appointment.
    13 for0 against
  • Re-appointment and remuneration to Dr. Ajay Thakker (DIN: 00120887) as Managing Director for further period of 5 years from October 01, 2024.
    Against Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance Concern: Holding CMD Position. No absolute cap on proposed remuneration.
    • Edelweiss Mutual FundMultiple resolutions in one. Remuneration is above thresholds
    • HDFC Mutual FundThe proposed remuneration is high considering the size and complexity of the business
    8 for5 against
  • Re-appointment and remuneration to Dr. Ankit Thakker (DIN: 02874715) as Whole Time Director for further period of 5 years from October 01, 2024.
    Against Bandhan Mutual Fund, Edelweiss Mutual Fund, Groww Mutual Fund, HDFC Mutual Fund, Motilal Oswal Mutual Fund
    • Bandhan Mutual Fund, Groww Mutual Fund, Motilal Oswal Mutual FundCompliant with law. Governance Concern: No absolute cap on proposed remuneration.
    • Edelweiss Mutual FundMultiple resolutions in one. Remuneration is above thresholds
    • HDFC Mutual FundThe proposed remuneration is high considering the size and complexity of the business
    8 for5 against
  • Ratification of remuneration payable to M/s. V. J. Talati & Co., Cost Accountants, as Cost Auditors for the Financial Year 2024 - 2025.
    13 for0 against

Each fund house counted once, from its own disclosure; the reasons are its own words.

Investor complaints and compliance

Quarter by quarter.

Investor complaints received and resolved, the company's own count

  • Received
  • Resolved

Open at the quarter's end

None open at any quarter's end.
The board is made up as the listing rules require
Yes
The board has a regular chairperson
Yes
The company has a risk management committee
Yes
The chair is related to the managing director
Yes
The filing has a part on fines and penalties
No
The filing has a part on tax disputes
No
There was a cyber security incident in the quarter
No

The company's own answers in its filing.

How money raised was used

The company's results filing for the quarter to Jun 2026 says no statement of how money raised was used applies to it.